Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling
Metformin , commonly prescribed for type 2 diabetes, can reduce B12 absorption with long-term use
Ask your doctor or pharmacist before combining use with Plavix, Brilinta or another antiplatelet medication
The Importance of Bioavailability One of the biggest challenges with both quercetin and glutathione is absorption
United States Patent US 5,538,945 (peptide-copper complexes for hair growth)
This makes it a focus in research on fundamental cellular processes rather than just acute energy provision
